Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.113705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Bellinda Lantzberg und 14 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany. Hauptthemen laut MEDLINE: Nanoparticle Drug Delivery System, Serum Albumin, Human, Immunologic Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Max-Planck-Gesellschaft, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Nanocarriers can improve the therapeutic efficiency of small molecule immunomodulators or inhibitors, which is important for immunotherapy of liver diseases or cancer. Macromolecular protein carriers, such as human serum albumin (HSA), could provide better penetration compared to large nanoparticles (>50 nm) but are hampered by systemic biodistribution. To overcome these limitations, inspired by the natural glycogen structure, we have designed the HSA nanocarrier (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.
- Department of Dermatology, University Medical Center of Johannes Gutenberg-University Mainz, Obere Zahlbacher Straße 63, 55131 Mainz, Germany.
- Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.
- Faculty for Chemistry and Pharmaceutics, Julius-Maximilians-University Würzburg, Röntgenring 11, 97070 Würzburg, Germany.
- Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany; State Key Laboratory of Natural Medicines, China Pharmaceutical University, 210009, PR China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, 210009, PR China.
Förderung
- Max-Planck-Gesellschaft
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Lantzberg, B., Zeyn, Y., Forster, R., Jian, L., Schauenburg, D., Hieber, C., Nuhn, L., Zhou, T., Silva, M. J. S. A., Koynov, K., Jiang, H. L., Kuan, S. L., Bros, M., Opatz, T., & Weil, T. (2025). Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.113705
Vancouver
Lantzberg B, Zeyn Y, Forster R, Jian L, Schauenburg D, Hieber C, et al. Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.113705
BibTeX
@article{Lantzberg2025,
author = {Lantzberg, Bellinda and Zeyn, Yanira and Forster, Robert and Jian, Lin and Schauenburg, Dominik and Hieber, Christoph and Nuhn, Lutz and Zhou, Tianjiao and Silva, Maria J S A and Koynov, Kaloian and Jiang, Hu-Lin and Kuan, Seah Ling and Bros, Matthias and Opatz, Till and Weil, Tanja},
title = {Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.113705}
}
EUVIMED